Patients treated with ligelizumab achieve freedom fromsigns and symptoms of chronic spontaneous urticaria regardless of the angioedema status at baseline

被引：0
|
作者：
Sitz, Karl [1 ]
Soong, Weily [2 ]
Bernstein, Jonathan A. [3 ,4 ]
机构：
[1] Little Rock Allergy & Asthma Clin, Little Rock, AR USA
[2] AllerVie Hlth, Alabama Allergy & Asthma Ctr, Clin Res Ctr Alabama, Birmingham, AL USA
[3] Univ Cincinnati, Coll Med, Cincinnati, OH USA
[4] Bernstein Clin Res Ctr, Cincinnati, OH USA
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2022年 / 87卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
33583
引用
收藏
页码：AB90 / AB90
页数：1
相关论文
共 50 条
  • [1] Ligelizumab Improves Dermatology Quality Of Life In Patients With Chronic Spontaneous Urticaria Regardless of Angioedema Status At Baseline
    Soong, Weily
    Bernstein, Jonathan
    Sitz, Karl
    Maurer, Marcus
    Gimenez-Arnau, Ana
    Ortmann, Christine-Elke
    Severin, Thomas
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2022, 149 (02) : AB180 - AB180
  • [2] Ligelizumab Achieves Freedom from Signs and Symptoms of Chronic Spontaneous Urticaria Regardless of the CU Index (Basophil Histamine Release Assay) Status at Baseline
    Sitz, Karl
    Bernstein, Jonathan
    Soong, Weily
    Maurer, Marcus
    Gimenez-Arnau, Ana Maria
    Hua, Eva
    Severin, Thomas
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2022, 149 (02) : AB179 - AB179
  • [3] LIGELIZUMAB ACHIEVES SUSTAINED CONTROL OF ANGIOEDEMA IN PATIENTS WITH CHRONIC SPONTANEOUS URTICARIA
    Soong, W.
    Lanier, B.
    Sitz, K.
    Kobayashi, K.
    Barve, A.
    Hua, E.
    Janocha, R.
    Severin, T.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2019, 123 (05) : S27 - S27
  • [4] Ligelizumab improves angioedema, disease severity and quality-of-life in patients with chronic spontaneous urticaria
    Metz, Martin
    Bernstein, Jonathan A.
    Gimenez-Arnau, Ana M.
    Hide, Michihiro
    Maurer, Marcus
    Sitz, Karl
    Soong, Weily
    Sussman, Gordon
    Hua, Eva
    Barve, Avantika
    Barbier, Nathalie
    Balp, Maria-Magdalena
    Severin, Thomas
    WORLD ALLERGY ORGANIZATION JOURNAL, 2022, 15 (11):
  • [5] Ligelizumab is more effective in patients with chronic spontaneous urticaria previously treated with omalizumab
    Sitz, Karl
    Sussman, Gordon
    Metz, Martin
    Hide, Michihiro
    Maurer, Marcus
    BarbierStatitiscian, Nathalie
    Hua, Eva
    Janocha, Reinhold
    Severin, Thomas
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2021, 147 (02) : AB158 - AB158
  • [6] A case of chronic spontaneous urticaria unresponsive to ligelizumab successfully treated with omalizumab
    Russo, Filomena
    Cortonesi, Giulio
    Lazzeri, Laura
    Taddeucci, Paolo
    Rubegni, Pietro
    DERMATOLOGIC THERAPY, 2022, 35 (11)
  • [7] Ligelizumab retreatment is highly effective in patients with chronic spontaneous urticaria
    Maurer, M.
    Gimenez-Arnau, A. M.
    Sussman, G.
    Hua, E.
    Severin, T.
    Janocha, R.
    ALLERGY, 2019, 74 : 22 - 23
  • [8] LIGELIZUMAB ACHIEVES FAST CONTROL OF SYMPTOMS IN MORE PATIENTS WITH CHRONIC SPONTANEOUS URTICARIA VERSUS OMALIZUMAB
    Severin, T.
    Soong, W.
    Maurer, M.
    Gimenez-Arnau, A.
    Hide, M.
    Bernstein, J.
    Hua, E.
    Barve, A.
    Janocha, R.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2020, 125 (05) : S13 - S13
  • [9] LIGELIZUMAB ACHIEVES FREEDOM FROM DISEASE ACTIVITY IN CHRONIC SPONTANEOUS URTICARIA REGARDLESS OF PREVIOUS H1-ANTIHISTAMINE DOSE
    Soong, W.
    Sitz, K.
    Bernstein, J.
    Maurer, M.
    Gimenez-Arnau, A.
    Hua, E.
    Severin, T.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2021, 127 (05) : S27 - S28
  • [10] Ligelizumab further reduced sleep impairment in patients with chronic spontaneous urticaria previously treated with omalizumab
    Maurer, Marcus
    Sitz, Karl
    Sussman, Gordon
    Metz, Martin
    Hide, Michihiro
    Gimenez-Arnau, Ana
    Barbier, Nathalie
    Hua, Eva
    Janocha, Reinhold
    Balp, Maria-Magdalena
    Severin, Thomas
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (03) : AB58 - AB58
12345